About The Study: This population-based cohort study of men with prostate cancer suggests that higher county-level prevalence of prostate-specific antigen (PSA) screening was associated with lower odds of advanced disease, all-cause mortality, and prostate cancer–specific mortality. Associations varied by age, race and ethnicity, and U.S. Census region.
Corresponding Author: To contact the corresponding author, Hari S. Iyer, Sc.D., M.P.H., email hari.iyer@rutgers.edu .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.14582)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.14582?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=060424
JAMA Network Open